{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:09:19Z","timestamp":1789038559298,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100023448","name":"Robert Koch-Institut","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Einleitung<\/jats:title>\n                    <jats:p>Angesichts des demografischen Wandels gewinnt die Pr\u00e4vention von St\u00fcrzen bei Hochaltrigen zunehmend an Bedeutung. Der Beitrag beschreibt das Sturzgeschehen bei Personen ab 80\u00a0Jahren in Deutschland und untersucht relevante Risikofaktoren mit besonderem Fokus auf den Arzneimittelgebrauch.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methoden<\/jats:title>\n                    <jats:p>Grundlage sind Daten der epidemiologischen L\u00e4ngsschnittstudie Gesundheit 65+ zur gesundheitlichen Lage \u00e4lterer Menschen in Deutschland. Analysiert wurden die 12-Monats-Sturzpr\u00e4valenz bei Personen ab 80\u00a0Jahren sowie Risikofaktoren wie vorangegangene St\u00fcrze, Polypharmazie (dauerhafte Einnahme von \u2265\u202f5\u00a0Arzneimitteln), sturzbeg\u00fcnstigende Arzneimittel (Fall-Risk-Increasing Drugs, FRIDs), k\u00f6rperliche und kognitive Einschr\u00e4nkungen sowie soziodemografische Merkmale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ergebnisse<\/jats:title>\n                    <jats:p>Die Studienpopulation umfasste 1742 Personen ab 80\u00a0Jahren. F\u00fcr die Medikamentenanalyse standen Daten von 742 Teilnehmenden zur Verf\u00fcgung. 38,1\u202f% berichteten bereits vor Studienbeginn mindestens einen Sturz. Innerhalb von 12\u00a0Monaten nach der Basisbefragung st\u00fcrzten 46,7\u202f% der Teilnehmenden. Die Polypharmazie-Pr\u00e4valenz lag bei 48,7\u202f% und 59,2\u202f% der Teilnehmenden nahmen mindestens ein FRID ein. Im adjustierten Regressionsmodell waren Harninkontinenz, Sehbeeintr\u00e4chtigung und depressive Symptomatik mit einer h\u00f6heren Sturzwahrscheinlichkeit verbunden. Polypharmazie und FRIDs zeigten ebenfalls eine Assoziation mit St\u00fcrzen, die nach Adjustierung nicht statistisch signifikant war.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diskussion<\/jats:title>\n                    <jats:p>Die hohe Sturzpr\u00e4valenz bei Menschen ab 80\u00a0Jahren verdeutlicht den Bedarf an wirksamerer Sturzpr\u00e4vention in Deutschland. Relevante Ansatzpunkte f\u00fcr Pr\u00e4ventionsma\u00dfnahmen sind insbesondere Mobilit\u00e4tseinschr\u00e4nkungen, fr\u00fchere St\u00fcrze, Harninkontinenz, Sehbeeintr\u00e4chtigung, depressive Symptomatik sowie Polypharmazie und FRIDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00103-026-04290-y","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:10:56Z","timestamp":1786695056000},"page":"1008-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["St\u00fcrze und Polypharmazie\u00a0\u2013 H\u00e4ufigkeiten und Ansatzpunkte f\u00fcr Pr\u00e4vention","Falls and polypharmacy\u2014an exploration of both the frequency and approaches to prevention"],"prefix":"10.1007","volume":"69","author":[{"given":"Judith","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Sarganas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinara","family":"Yessimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"4290_CR1","unstructured":"Balzer K, Bremer M, Schramm S, L\u00fchmann D, Raspe H (2012) Sturzprophylaxe bei \u00e4lteren Menschen in ihrer pers\u00f6nlichen Wohnumgebung. In: HTA-Bericht 116. Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (DIMDI), K\u00f6ln. Zugegriffen: 30. Juni 2026"},{"key":"4290_CR2","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1532-5415.2005.53455.x","volume":"53","author":"SE Lamb","year":"2005","unstructured":"Lamb\u00a0SE, J\u00f8rstad-Stein\u00a0EC, Hauer\u00a0K, Becker\u00a0C (2005) Development of a\u00a0common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J\u00a0Am Geriatr Soc 53:1618\u20131622. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53455.x","journal-title":"J Am Geriatr Soc"},{"key":"4290_CR3","unstructured":"World Health Organization, Ageing And Life Course Unit, World Health Organization (Hrsg) (2008) WHO global report on falls prevention in older age. https:\/\/www.loc.gov\/item\/2021763108\/. Zugegriffen: 30. Juni 2026"},{"key":"4290_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf157","author":"E Rommers","year":"2025","unstructured":"Rommers\u00a0E, De Pauw\u00a0R, Petrovic\u00a0M, Cambier\u00a0D (2025) Epidemiology of falls in community-dwelling older adults in Europe: a systematic review and meta-analysis. Age Ageing.\u00a0Volume 54, Issue 6, June 2025, afaf157,\u00a0https:\/\/doi.org\/10.1093\/ageing\/afaf157","journal-title":"Age Ageing"},{"key":"4290_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.maturitas.2013.02.009","volume":"75","author":"AF Ambrose","year":"2013","unstructured":"Ambrose\u00a0AF, Paul\u00a0A, Hausdorff\u00a0JM (2013) Risk factors for falls among older adults: a review of the literature. Maturitas 75:51\u201361. https:\/\/doi.org\/10.1016\/j.maturitas.2013.02.009","journal-title":"Maturitas"},{"key":"4290_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40621-023-00418-9","volume":"10","author":"A Farrell","year":"2023","unstructured":"Farrell\u00a0A, Castro\u00a0T, Nalubola\u00a0S, Lakhi\u00a0N (2023) Trauma-related falls in an urban geriatric population: predictive risk factors for poorer clinical outcomes. Inj Epidemiol 10:7. https:\/\/doi.org\/10.1186\/s40621-023-00418-9","journal-title":"Inj Epidemiol"},{"key":"4290_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10433-004-0008-z","volume":"1","author":"DA Skelton","year":"2004","unstructured":"Skelton\u00a0DA, Becker\u00a0C, Lamb\u00a0SE et\u00a0al (2004) Prevention of Falls Network Europe: a thematic network aimed at introducing good practice in effective falls prevention across Europe. Eur J Ageing 1:89\u201394. https:\/\/doi.org\/10.1007\/s10433-004-0008-z","journal-title":"Eur J Ageing"},{"key":"4290_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11914-008-0026-4","volume":"6","author":"SD Berry","year":"2008","unstructured":"Berry\u00a0SD, Miller\u00a0RR (2008) Falls: epidemiology, pathophysiology, and relationship to fracture. Current osteoporosis reports 6:149\u2013154.\u00a0doi: https:\/\/doi.org\/10.1007\/s11914-008-0026-4. PMID: 19032925; PMCID: PMC2793090","journal-title":"Current osteoporosis reports"},{"key":"4290_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/EDE.0b013e3181e89905","volume":"21","author":"S Deandrea","year":"2010","unstructured":"Deandrea\u00a0S, Lucenteforte\u00a0E, Bravi\u00a0F, Foschi\u00a0R, La Vecchia\u00a0C, Negri\u00a0E (2010) Risk factors for falls in community-dwelling older people: a\u00a0systematic review and meta-analysis. Epidemiology (Cambridge, Mass.) 21:658\u2013668. https:\/\/doi.org\/10.1097\/EDE.0b013e3181e89905","journal-title":"Epidemiology (Cambridge, Mass.)"},{"key":"4290_CR10","unstructured":"Robert Koch-Institut (2024) St\u00fcrze (ab 65 Jahre) In: Gesundheitsberichterstattung des Bundes (ed)Robert Koch-Institut. https:\/\/gbe.rki.de. Zugegriffen: 30. Juni 2026"},{"key":"4290_CR11","unstructured":"DESTATIS (2021) 15. koordinierte Bev\u00f6lkerungsvorausberechnung. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Bevoelkerungsvorausberechnung\/begleitheft.html. Zugegriffen: 30. Juni 2026"},{"key":"4290_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1019094","volume":"9","author":"Y Li","year":"2022","unstructured":"Li\u00a0Y, Hou\u00a0L, Zhao\u00a0H, Xie\u00a0R, Yi\u00a0Y, Ding\u00a0X (2022) Risk factors for falls among community-dwelling older adults: A\u00a0systematic review and meta-analysis. Front Med 9:1019094. https:\/\/doi.org\/10.3389\/fmed.2022.1019094","journal-title":"Front Med (Lausanne)"},{"key":"4290_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2025.105765","volume":"26","author":"S Saunders","year":"2025","unstructured":"Saunders\u00a0S, D\u2019Amore\u00a0C, Hao\u00a0Q et\u00a0al (2025) Risk Factors for Falls in Community-Dwelling Older Adults: An Umbrella Review. J\u00a0Am Med Dir Assoc 26:105765. https:\/\/doi.org\/10.1016\/j.jamda.2025.105765","journal-title":"J Am Med Dir Assoc"},{"key":"4290_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-662-72460-6_3","volume-title":"Arzneimittel-Kompass 2025","author":"P Th\u00fcrmann","year":"2025","unstructured":"Th\u00fcrmann\u00a0P, Bencheva\u00a0V, Schmiedl\u00a0S (2025) Demographischer Wandel: Angemessene Arzneimittelversorgung einer alternden Bev\u00f6lkerung. In: Schr\u00f6der\u00a0H et\u00a0al (Hrsg) Arzneimittel-Kompass 2025, S\u00a037\u201357"},{"key":"4290_CR15","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1111\/bcp.16113","volume":"90","author":"M Bennie","year":"2024","unstructured":"Bennie\u00a0M, Santa-Ana-Tellez\u00a0Y, Galistiani\u00a0GF et\u00a0al (2024) The prevalence of polypharmacy in older Europeans: A multi-national database study of general practitioner prescribing. Br J Clin Pharmacol 90:2124\u20132136. https:\/\/doi.org\/10.1111\/bcp.16113","journal-title":"Br J Clin Pharmacol"},{"key":"4290_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","volume":"396","author":"SE Vollset","year":"2020","unstructured":"Vollset\u00a0SE, Goren\u00a0E, Yuan\u00a0CW et\u00a0al (2020) Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet 396:1285\u20131306. https:\/\/doi.org\/10.1016\/S0140-6736(20)30677-2","journal-title":"Lancet"},{"key":"4290_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon\u00a0N, Shakib\u00a0S, Kalisch-Ellett\u00a0L, Caughey\u00a0GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr"},{"key":"4290_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie\u00a0B, Makubate\u00a0B, Hernandez-Santiago\u00a0V, Dreischulte\u00a0T (2015) The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med 13:74. https:\/\/doi.org\/10.1186\/s12916-015-0322-7","journal-title":"BMC Med"},{"key":"4290_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/clpt.2008.224","volume":"85","author":"SN Hilmer","year":"2009","unstructured":"Hilmer\u00a0SN, Gnjidic\u00a0D (2009) The effects of polypharmacy in older adults. Can J Hosp Pharm 85:86\u201388. https:\/\/doi.org\/10.1038\/clpt.2008.224","journal-title":"Clin Pharmacol Ther"},{"key":"4290_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40262-024-01466-0","volume":"64","author":"NN Ngcobo","year":"2025","unstructured":"Ngcobo\u00a0NN (2025) Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review. Clin Pharmacokinet 64:335\u2013367. https:\/\/doi.org\/10.1007\/s40262-024-01466-0","journal-title":"Clin Pharmacokinet"},{"key":"4290_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies\u00a0LE, Spiers\u00a0G, Kingston\u00a0A, Todd\u00a0A, Adamson\u00a0J, Hanratty\u00a0B (2020) Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J\u00a0Am Med Dir Assoc 21:181\u2013187. https:\/\/doi.org\/10.1016\/j.jamda.2019.10.022","journal-title":"J Am Med Dir Assoc"},{"key":"4290_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40264-025-01614-w","volume":"49","author":"M Schechner","year":"2026","unstructured":"Schechner\u00a0M, Rottenkolber\u00a0M, Weglage\u00a0C et\u00a0al (2026) Implied ADR-Admissions: A\u00a0Cohort Study Introducing a\u00a0Novel Administrative Data Approach for Identifying Drug-Related Hospitalisations. Drug Saf 49:337\u2013351. https:\/\/doi.org\/10.1007\/s40264-025-01614-w","journal-title":"Drug Saf"},{"key":"4290_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09920-x","volume":"20","author":"P Zaninotto","year":"2020","unstructured":"Zaninotto\u00a0P, Huang\u00a0YT, Di Gessa\u00a0G, Abell\u00a0J, Lassale\u00a0C, Steptoe\u00a0A (2020) Polypharmacy is a\u00a0risk factor for hospital admission due to a\u00a0fall: evidence from the English Longitudinal Study of Ageing. BMC Public Health 20:1804. https:\/\/doi.org\/10.1186\/s12889-020-09920-x","journal-title":"BMC Public Health"},{"key":"4290_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2125.2005.02543.x","volume":"61","author":"G Ziere","year":"2006","unstructured":"Ziere\u00a0G, Dieleman\u00a0JP, Hofman\u00a0A, Pols\u00a0HA, van der Cammen\u00a0TJ, Stricker\u00a0BH (2006) Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 61:218\u2013223. https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02543.x","journal-title":"Br J Clin Pharmacol"},{"key":"4290_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016358","volume":"7","author":"NN Dhalwani","year":"2017","unstructured":"Dhalwani\u00a0NN, Fahami\u00a0R, Sathanapally\u00a0H, Seidu\u00a0S, Davies\u00a0MJ, Khunti\u00a0K (2017) Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open 7:e016358. https:\/\/doi.org\/10.1136\/bmjopen-2017-016358","journal-title":"BMJ Open"},{"key":"4290_CR26","doi-asserted-by":"publisher","first-page":"371.e371","DOI":"10.1016\/j.jamda.2017.12.013","volume":"19","author":"M de Vries","year":"2018","unstructured":"de Vries\u00a0M, Seppala\u00a0LJ, Daams\u00a0JG, van de Glind\u00a0EMM, Masud\u00a0T, van der Velde\u00a0N (2018) Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: I. Cardiovascular Drugs. J\u00a0Am Med Dir Assoc 19:371.e371\u2013371.e379. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.013","journal-title":"J Am Med Dir Assoc"},{"key":"4290_CR27","doi-asserted-by":"publisher","first-page":"372.e371","DOI":"10.1016\/j.jamda.2017.12.099","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala\u00a0LJ, van de Glind\u00a0EMM, Daams\u00a0JG et\u00a0al (2018) Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: III. Others. J\u00a0Am Med Dir Assoc 19:372.e371\u2013372.e378. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.099","journal-title":"J Am Med Dir Assoc"},{"key":"4290_CR28","doi-asserted-by":"publisher","first-page":"371.e311","DOI":"10.1016\/j.jamda.2017.12.098","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala\u00a0LJ, Wermelink\u00a0A, de Vries\u00a0M et\u00a0al (2018) Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics. J\u00a0Am Med Dir Assoc 19:371.e311\u2013371.e317. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.098","journal-title":"J Am Med Dir Assoc"},{"key":"4290_CR29","unstructured":"The American Association for Public Opinion Research (AAPOR) (2016) Standard definitions: final dispositions of case codes and outcome rates for surveys. https:\/\/aapor.org\/wp-content\/uploads\/2022\/11\/Standard-Definitions20169theditionfinal.pdf. Zugegriffen: 30. Juni 2026"},{"key":"4290_CR30","doi-asserted-by":"publisher","unstructured":"Fuchs J, Gaertner B, Perlitz H et al. (2023) Studie zur Gesundheit \u00e4lterer Menschen in Deutschland (Gesundheit 65+): Zielsetzung, Konzeption und Durchf\u00fchrung. Journal of Health Monitoring:66\u2013\u201390. https:\/\/doi.org\/10.25646\/11662","DOI":"10.25646\/11662"},{"key":"4290_CR31","unstructured":"Eurostat (2018) European Health Interview Survey (EHIS wave 3) \u2014 Methodological manual. https:\/\/ec.europa.eu\/eurostat\/documents\/3859598\/8762193\/KS-02-18-240-EN-N.pdf\/5fa53ed4-4367-41c4-b3f5-260ced9ff2f6?t=1521718236000. Zugegriffen: 30. Juni 2026"},{"key":"4290_CR32","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1017\/s0033291707001122","volume":"37","author":"F Jessen","year":"2007","unstructured":"Jessen\u00a0F, Wiese\u00a0B, Cvetanovska\u00a0G et\u00a0al (2007) Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med 37:1753\u20131762. https:\/\/doi.org\/10.1017\/s0033291707001122","journal-title":"Psychol Med"},{"key":"4290_CR33","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.Mlr.0000093487.78664.3c","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke\u00a0K, Spitzer\u00a0RL, Williams\u00a0JB (2003) The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 41:1284\u20131292. https:\/\/doi.org\/10.1097\/01.Mlr.0000093487.78664.3c","journal-title":"Med Care"},{"key":"4290_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnr.2025.151982","volume":"84","author":"S Jeevanji","year":"2025","unstructured":"Jeevanji\u00a0S, Mean\u00a0M, Aubert\u00a0CE, Hilfiker\u00a0R, Gentizon\u00a0J (2025) Prevalence and types of fall-risk-increasing drugs identified by STOPPFall in hospitalized older adults: A retrospective observational study. Appl Nurs Res 84:151982. https:\/\/doi.org\/10.1016\/j.apnr.2025.151982","journal-title":"Appl Nurs Res"},{"key":"4290_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf138","author":"K Doyle","year":"2025","unstructured":"Doyle\u00a0K, Scarlett\u00a0S, Knight\u00a0SP et\u00a0al (2025) The association between STOPPFall medication use and falls and fractures in community-dwelling older people. Age Ageing.\u00a02025 May 3;54(5):afaf138. doi: https:\/\/doi.org\/10.1093\/ageing\/afaf138. PMID: 40439666; PMCID: PMC12120935.","journal-title":"Age Ageing"},{"key":"4290_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/ageing\/afaa249","volume":"50","author":"LJ Seppala","year":"2021","unstructured":"Seppala\u00a0LJ, Petrovic\u00a0M, Ryg\u00a0J et\u00a0al (2021) STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a\u00a0Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing 50:1189\u20131199. https:\/\/doi.org\/10.1093\/ageing\/afaa249","journal-title":"Age Ageing"},{"key":"4290_CR37","unstructured":"Lechert Y, Schroedter JH, L\u00fcttinger P, Gesis (2006) Die Umsetzung der Bildungsklassifikation CASMIN f\u00fcr die Volksz\u00e4hlung 1970, die Mikrozensus-Zusatzerhebung 1971 und die Mikrozensen 1976-2004. https:\/\/nbn-resolving.org\/urn:nbn:de:0168-ssoar-262353"},{"key":"4290_CR38","volume-title":"Regionale Standards Ausgabe 2019","author":"KBF Behrens","year":"2019","unstructured":"Behrens\u00a0KBF, Dittmar\u00a0H et\u00a0al (2019) Regionale Standards: Ausgabe 2019. In: Arbeitsgruppe Regionale Standards (Hrsg) Regionale Standards Ausgabe 2019. GESIS \u2013 Leibniz-Institut f\u00fcr Sozialwissenschaften, K\u00f6ln"},{"key":"4290_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015827","volume":"7","author":"CB Franse","year":"2017","unstructured":"Franse\u00a0CB, Rietjens\u00a0JA, Burdorf\u00a0A et\u00a0al (2017) A prospective study on the variation in falling and fall risk among community-dwelling older citizens in 12 European countries. BMJ Open 7:e015827. https:\/\/doi.org\/10.1136\/bmjopen-2017-015827","journal-title":"BMJ Open"},{"key":"4290_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac205","author":"M Montero-Odasso","year":"2022","unstructured":"Montero-Odasso\u00a0M, van der Velde\u00a0N, Martin\u00a0FC et\u00a0al (2022) World guidelines for falls prevention and management for older adults: a\u00a0global initiative. Age Ageing.\u00a02022 Sep 2;51(9):afac205. doi: https:\/\/doi.org\/10.1093\/ageing\/afac205. Erratum in: Age Ageing. 2023 Sep 1;52(9):afad188. doi: https:\/\/doi.org\/10.1093\/ageing\/afad188. Erratum in: Age Ageing. 2023 Oct 2;52(10):afad199. doi: https:\/\/doi.org\/10.1093\/ageing\/afad199. PMID: 36178003; PMCID: PMC9523684.","journal-title":"Age Ageing"},{"key":"4290_CR41","volume-title":"Expertenstandard Sturzprophylaxe in der Pflege","year":"2022","unstructured":"DNQP \u2013 Deutsches Netzwerk f\u00fcr Qualit\u00e4tsentwicklung in der Pflege (Hrsg) (2022) Expertenstandard Sturzprophylaxe in der Pflege, 2. Aktualisierung.\u00a0Aufl. Osnabr\u00fcck, Deutschland","edition":"2. Aktualisieru"},{"key":"4290_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17197234","author":"LB Diaz","year":"2020","unstructured":"Diaz\u00a0LB, Casuso-Holgado\u00a0MJ, Labajos-Manzanares\u00a0MT et\u00a0al (2020) Analysis of Fall Risk Factors in an Aging Population Living in Long-Term Care Institutions in SPAIN: A Retrospective Cohort Study. Int J Environ Res Public Health.\u00a02020 Oct 3;17(19):7234. doi: https:\/\/doi.org\/10.3390\/ijerph17197234. PMID: 33022932; PMCID: PMC7579165.","journal-title":"Int J Environ Res Public Health"},{"issue":"Suppl 1","key":"4290_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/ggi.14760","volume":"24","author":"Y Yoshida","year":"2024","unstructured":"Yoshida\u00a0Y, Ishizaki\u00a0T, Masui\u00a0Y et\u00a0al (2024) Effect of number of medications on the risk of falls among community-dwelling older adults: A\u00a03-year follow-up of the SONIC study. Geriatr Gerontol Int 24(Suppl 1):306\u2013310. https:\/\/doi.org\/10.1111\/ggi.14760","journal-title":"Geriatr Gerontol Int"},{"key":"4290_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/ageing\/afu141","volume":"44","author":"K Richardson","year":"2015","unstructured":"Richardson\u00a0K, Bennett\u00a0K, Kenny\u00a0RA (2015) Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing 44:90\u201396. https:\/\/doi.org\/10.1093\/ageing\/afu141","journal-title":"Age Ageing"},{"key":"4290_CR45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00325481.2014.996112","volume":"127","author":"A Zia","year":"2015","unstructured":"Zia\u00a0A, Kamaruzzaman\u00a0SB, Tan\u00a0MP (2015) Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk. Postgrad Med 127:330\u2013337. https:\/\/doi.org\/10.1080\/00325481.2014.996112","journal-title":"Postgrad Med"},{"key":"4290_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02695-9","volume":"21","author":"L Xue","year":"2021","unstructured":"Xue\u00a0L, Boudreau\u00a0RM, Donohue\u00a0JM et\u00a0al (2021) Persistent polypharmacy and fall injury risk: the Health, Aging and Body Composition Study. BMC Geriatr 21:710. https:\/\/doi.org\/10.1186\/s12877-021-02695-9","journal-title":"BMC Geriatr"},{"key":"4290_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.archger.2014.09.006","volume":"60","author":"RJ Mitchell","year":"2015","unstructured":"Mitchell\u00a0RJ, Lord\u00a0SR, Harvey\u00a0LA, Close\u00a0JC (2015) Obesity and falls in older people: mediating effects of disease, sedentary behavior, mood, pain and medication use. Arch Gerontol Geriatr Plus 60:52\u201358. https:\/\/doi.org\/10.1016\/j.archger.2014.09.006","journal-title":"Arch Gerontol Geriatr"},{"key":"4290_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0989","volume":"86","author":"M Umapathy","year":"2025","unstructured":"Umapathy\u00a0M, Narvaez-Vega\u00a0K, Khoshnaw\u00a0H (2025) Medication Management to Reduce Falls-With Particular Focus on Frailty, Polypharmacy and Prescribing. Br J Hosp Med 86:1\u201316. https:\/\/doi.org\/10.12968\/hmed.2024.0989","journal-title":"Br J Hosp Med (Lond)"},{"key":"4290_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s41999-021-00448-w","volume":"12","author":"SA Sternberg","year":"2021","unstructured":"Sternberg\u00a0SA, Rochon\u00a0PA, Gurwitz\u00a0JH (2021) Focusing on medications that increase the risk of falls in older adults. Eur Geriatr Med 12:671\u2013672. https:\/\/doi.org\/10.1007\/s41999-021-00448-w","journal-title":"Eur Geriatr Med"},{"key":"4290_CR50","doi-asserted-by":"publisher","unstructured":"Lee J, Negm A, Peters R, Wong EKC, Holbrook A (2021) Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a\u00a0systematic review and meta-analysis. BMJ Open\u00a011:e035978. https:\/\/doi.org\/10.1136\/bmjopen-2019-035978","DOI":"10.1136\/bmjopen-2019-035978"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04290-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-026-04290-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04290-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:22:09Z","timestamp":1789035729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-026-04290-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4290"],"URL":"https:\/\/doi.org\/10.1007\/s00103-026-04290-y","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Fuchs, G.\u00a0Sarganas, D.\u00a0Yessimova und E.\u00a0Grill geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Diese Studie wurde von der Ethikkommission der Berliner \u00c4rztekammer gepr\u00fcft und f\u00fcr unbedenklich erkl\u00e4rt (Ethikvotum Nr. Eth-50\/19). Sie wurde in \u00dcbereinstimmung mit der Deklaration von Helsinki durchgef\u00fchrt. Alle Teilnehmenden wurden \u00fcber die Ziele der Studie informiert und haben freiwillig und pseudonymisiert teilgenommen. Die Studie Gesundheit 65+ wurde unter strikter Einhaltung der datenschutzrechtlichen Bestimmungen der EU-Datenschutzgrundverordnung (DSGVO) und des Bundesdatenschutzgesetzes (BDSG) durchgef\u00fchrt. Im Vorfeld der Studie wurde die Durchf\u00fchrung der Studie durch die beh\u00f6rdliche Datenschutzbeauftrage des Robert Koch-Instituts als unbedenklich bewertet.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}